Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
19,842,878
-
Share change
-
-10,186,977
-
Total reported value
-
$5,660,592
-
Put/Call ratio
-
0%
-
Price per share
-
$0.29
-
Number of holders
-
44
-
Value change
-
-$5,292,735
-
Number of buys
-
13
-
Number of sells
-
19
Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) as of Q1 2022
As of 31 Mar 2022,
ACELRX PHARMACEUTICALS INC - COM (ACRX) was held by
44 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,842,878 shares.
The largest 10 holders included
Rock Springs Capital Management LP, D. E. Shaw & Co., Inc., VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Values First Advisors, Inc., STATE STREET CORP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, and Engineers Gate Manager LP.
This page lists
44
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.